A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

NCT03168880 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

720

Enrollment

OTHER_GOV

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Paclitaxel + Carboplatin
DRUG: Paclitaxel only

Sponsor

Tata Memorial Hospital